Active

Contract Opportunity

THIS IS A SOURCES SOUGHT NOTICE ONLY. This notice does NOT constitute a request for quote (RFQ), request for proposal (RFP), or invitation for bid (IFB). No solicitation is currently available. This Sources Sought is issued solely for information and planning purposes to conduct market research and determine the availability and capability of qualified sources prior to determining the appropriate acquisition strategy.

I. General Information

- Agency/Office: Department of Veterans Affairs (VA), VA North Texas Health Care System (VANTHCS), 4500 S. Lancaster Rd. Dallas, TX. 75216
- Place of Performance: VA North Texas Health Care System, Pathology and Laboratory Medicine Service (P&LMS), Microbiology Laboratory, Dallas, Texas.
- Anticipated NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing
- Anticipated PSC: 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets.

The Government is seeking to identify responsible vendors capable of providing Blood Bank Reagents, used to perform patient manual blood typing and serum antibody detection and identification to be used in the Transfusion Medicine Unit, Pathology and Laboratory Medicine Services at VANTHCS.
II. Description of Requirement
Transfusion Medicine Unit, Pathology and Laboratory Medicine Services (P&LMS) at the VA North Texas Health Care System (VANTHCS), Dallas, TX is seeking blood reagents used to perform patient manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions.
The contemplated purchase includes, at a minimum:
The Contractor shall provide reagent supplies as requested by VANTHCS staff to perform blood bank manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions.
Estimated Yearly Requirements:
Item #
Description/Part Number*
Qty
Unit
1
Z401U, ALBAcyte A1 Cells
52
EA
2
Z406U, ALBAcyte A2 Cells
13
EA
3
Z411U, ALBAcyte B Cells
52
EA
4
Z4411U-1, ALBAcyte IgG Sensitized Cells (weak)
26
EA
5
Z473U, ALBAcyte Antibody ID Panel (16-cell)
7
EA
6
Z482U, ALBAcyte C3 Coated Red Blood Cells
13
EA

Period of Performance:
Base Year: 05/01/2027-04/30/2028
Option Year 1: 05/01/2028-04/30/2029
Option Year 2: 05/01/2029-04/30/2030
Option Year 3: 05/01/2030-04/30/2031
Option Year 4: 05/01/2031-04/30/2032

Location: The manual testing will be performed in Transfusion Medicine Unit, Pathology & Laboratory Medicine Service, VA North Texas Health Care System, 4500 S. Lancaster Rd., Dallas, TX 75216.

III. Performance requirements:
Performance Requirements: The following are required:
Packing and Delivery:
All Shipping/Freight Charges will be FOB Destination unless noted otherwise by vendor and communicated to the contracting officer prior to award.
The reagents shall be delivered at the time specified when the order is placed. The Contractor will furnish appropriate containers for shipment of the reagents.

Vendor must be approved by the FDA and shall provide documentation of approval.

Vendor must have a defined Quality plan, and Adequate supplies available.

IV. Submission Instructions
Interested and capable vendors should submit an electronic capability statement and include the place of manufacture for all reagents listed in the sources sought via email in PDF or Word format by November 5, 2026, by 9:00 AM Central Standard Time.

- Teresa Arzola Â
- Email: Teresa.arzola@va.gov Â
- Subject line: Sources Sought Blood Bank Reagents VA North Texas HCS Â

No telephone inquiries will be accepted. Responses received will be used solely for market research and planning purposes to assist the Government in determining an appropriate acquisition strategy (e.g., small business set aside or unrestricted). Submission of a capability statement is voluntary and shall not be construed as a commitment by the Government to issue a solicitation or award a contract, nor will the Government pay for information submitted in response to this Sources Sought.

Attachments/Links